Expert Perspective Research

Accelerate Global Market Access with Strategic Evidence Generation

pie chart with Value Strategy, Value Assessment, and Value Communication in equal piecesIn a competitive global landscape, pharmaceutical companies face increasing pressure to demonstrate the value of their products—not just to patients and physicians, but to payers, policymakers, and health technology assessment (HTA) bodies across diverse markets.

At RTI-HS, we specialize in helping global pharma navigate the complexities of pricing, reimbursement, and access. Our targeted research and strategic engagement ensure your product meets the expectations of decision-makers worldwide.

We can help you answer critical questions about:

  • Payer perspectives and value drivers
  • Price value mapping
  • Critical pathway and landscape assessments
  • Reimbursement issues to address in your value arguments
  • Treatment attributes that influence pricing, reimbursement, and access decisions
  • Evidence gaps and approaches to fill them
  • Health equity and addressing disparities in marginalized populations
Over the years, I have become selective about whether and how I participate in research projects conducted on behalf of manufacturers. RTI-HS is the only firm that consistently engages me on the issues that actually matter in P&T committee decision-making. I have a great relationship with the RTI-HS researchers—they are senior-level and experienced, and their approach is thorough and thoughtful. My time is valuable, and while RTI-HS consults with me for my expert opinion, I often find our interactions intellectually engaging and educational.
RTI-HS Advisor Since 2010
Executive Vice President, Pharmacy National PBM (35M+ Members)

Engage the Right Stakeholders, Globally

With a growing number of public, private, and non-traditional payers—and rapidly evolving priorities—understanding what drives access decisions is essential. We help you connect with national, regional, and local payer bodies and HTA agencies, including:

  • CMS (U.S.)
  • CADTH (Canada)
  • NICE (UK)
  • IQWiG (Germany)
  • HAS (France)

Through proactive engagement and evidence generation, we help you understand the clinical and economic data required to secure reimbursement and ensure your product reaches the patients who need it.

To ensure a well-rounded view of your product’s value, we can conduct clinician interviews and assemble multi-stakeholder advisory boards. These engagements inform your product strategy, positioning, and value messaging—helping you align with the expectations of both clinical and payer audiences.

Global Insights from Trusted Payer Advisory Panels

Understanding payer perspectives is essential to securing access and reimbursement for your products across international markets. At RTI-HS, we offer exclusive access to a global network of payer experts through our customized advisory panels—designed to deliver actionable insights that shape strategy and drive success.

Expert Voices That Matter

Our payer advisory panel includes influential decision-makers such as:

  • current member of NICE’s appraisal committee
  • The Chief Medical Officer of a leading private U.S. insurer
  • The Pharmacy Director of a major national PBM

These experts provide firsthand insights into the evolving expectations of pricing and reimbursement bodies worldwide.

Tailored Methodologies for Strategic Clarity

Depending on your product and market needs, we select the right mix of methodologies to uncover the most relevant insights:

  • Advisory panels
  • Focus groups
  • In-depth interviews
  • Surveys
  • Delphi panels
  • Mock P&T committees

We also convene payer education boards to address negative coverage policies in the U.S. and tackle disease-specific concerns globally.

Featured Publications

Meet our Expert